![algomed on X: "Chads 2 vasc score used to calculate stroke risk in patients with atrial fibrillation. https://t.co/jzQVH3l82L https://t.co/6S5gVwSk0e" / X algomed on X: "Chads 2 vasc score used to calculate stroke risk in patients with atrial fibrillation. https://t.co/jzQVH3l82L https://t.co/6S5gVwSk0e" / X](https://pbs.twimg.com/media/DKVMoPgW0AAsk3B.jpg)
algomed on X: "Chads 2 vasc score used to calculate stroke risk in patients with atrial fibrillation. https://t.co/jzQVH3l82L https://t.co/6S5gVwSk0e" / X
![Chandra Ohri on X: "When should you use anticoagulants for patients with AF? Use #CHADSVASC to determine #Stroke risk for patients with #AF #MedEd https://t.co/OeuaR5s9Fw" / X Chandra Ohri on X: "When should you use anticoagulants for patients with AF? Use #CHADSVASC to determine #Stroke risk for patients with #AF #MedEd https://t.co/OeuaR5s9Fw" / X](https://pbs.twimg.com/media/DzybtAsW0AErtXr.jpg)
Chandra Ohri on X: "When should you use anticoagulants for patients with AF? Use #CHADSVASC to determine #Stroke risk for patients with #AF #MedEd https://t.co/OeuaR5s9Fw" / X
![Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1a84262bf2416f30f2c400e67d530b3957f84ba5/3-Table2-1.png)
Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar
![Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem? Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?](https://www.escardio.org/static-file/Escardio/Medias/councils/council-for-cardiology-practice/news/Figure%201.%20Decision%20tree%20for%20oral%20anticoagulation%20in%20patients%20with%20atrial%20fibrillation.jpg?mts=1592578501000.jpg)
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?
![Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? - ScienceDirect Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109714073914-gr2.jpg)
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? - ScienceDirect
![Table 1 from CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major Table 1 from CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major](https://d3i71xaburhd42.cloudfront.net/14bf0ef310d738231e77b4c0b03ba102871d06a8/3-Table1-1.png)
Table 1 from CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major
![CHA₂DS₂-VASc Risk Calculator Released | Stanford Emerging Applications Lab (SEAL) | Stanford Medicine CHA₂DS₂-VASc Risk Calculator Released | Stanford Emerging Applications Lab (SEAL) | Stanford Medicine](https://med.stanford.edu/seal/news/cha2ds2vasc-02-2021/_jcr_content/main/image_581775312.img.620.high.jpeg/CHADS2VASC-Example.jpeg)